Australian Healthtech Stock News

ASX:WDS
ASX:WDSOil and Gas

Assessing Woodside Energy Group’s Valuation After Record FY25 Output And Higher Dividend Fuel Market Optimism

Woodside Energy Group (ASX:WDS) is back in focus after record FY25 production, an increased dividend of US$0.59 per share, and a sharp share price move linked to oil supply fears in West Asia. See our latest analysis for Woodside Energy Group. Those production records and the higher dividend have arrived alongside strong recent momentum, with a 19.0% 1 month share price return, a 29.97% year to date share price return and a 44.95% 1 year total shareholder return, suggesting sentiment has...
ASX:TAH
ASX:TAHHospitality

A Look At Tabcorp Holdings’s Valuation After A Higher Interim Dividend Despite Lower Half Year Earnings

Tabcorp Holdings (ASX:TAH) has lifted investor focus after announcing an interim unfranked dividend of 1.5 cents per share, a 50% increase on the prior period, alongside its latest half year earnings. See our latest analysis for Tabcorp Holdings. At a share price of A$1.015, Tabcorp’s recent 16.0% 1 month share price return and 7.41% 3 month share price return contrast with a softer 7 day move. The 60.01% 1 year total shareholder return suggests momentum has been building over a longer period...
ASX:BGA
ASX:BGAFood

Does Bega Cheese’s (ASX:BGA) Updated DRP Reveal a Deeper Capital Allocation Shift?

Bega Cheese recently updated its dividend notice for the six‑month period ended 28 December 2025, confirming the cash distribution details and setting the price for its dividend reinvestment plan to guide share-based payouts. This clarification of dividend and reinvestment terms highlights Bega Cheese’s focus on disciplined capital management and consistent cash returns as part of its broader shareholder value approach. We’ll now examine how this clarified dividend reinvestment plan and...
ASX:ZIP
ASX:ZIPConsumer Finance

A Look At Zip Co (ASX:ZIP) Valuation After Results Update And US Expansion Plans

What sparked the latest move in Zip Co shares? Zip Co (ASX:ZIP) has been back in focus after first half fiscal 2026 results, where strong income, transaction volume, and profitability met flatter second half guidance and tighter margins, prompting a rethink of the share price move. See our latest analysis for Zip Co. That 3.65% 1 day share price return to A$1.845 comes after a tougher period, with the 30 day share price return of 26.79% and year to date share price return of 44.93% both...
ASX:COH
ASX:COHMedical Equipment

Cochlear’s Nucleus Nexa Launch Prompts Fresh Look At Valuation And Future Growth Potential

What Cochlear’s Nucleus Nexa launch could mean for shareholders Cochlear (ASX:COH) has launched its Nucleus Nexa System, a smart cochlear implant with upgradeable firmware and built in memory, now available in India from March 1, 2026. This product launch adds another option to Cochlear’s implantable hearing solutions portfolio, giving investors a fresh event to consider alongside the company’s current share price and recent share performance. See our latest analysis for Cochlear. Despite...
ASX:CSL
ASX:CSLBiotechs

Assessing CSL (ASX:CSL) Valuation After Expanded Buy Back And New Canadian Vaccine Contract

CSL (ASX:CSL) is back in focus after two fresh developments: a larger on market share buy back now covering nearly four million shares, and a new Canadian pandemic influenza vaccine contract for CSL Seqirus. See our latest analysis for CSL. Despite the fresh buy back and the Canadian vaccine contract, CSL's share price has had a weak patch, with a 30 day share price return of 19.5% and a 1 year total shareholder return decline of 42.6%, pointing to fading momentum after several tougher...
ASX:MSB
ASX:MSBBiotechs

The Bull Case For Mesoblast (ASX:MSB) Could Change Following Surging Ryoncil Revenue And 2026 Guidance - Learn Why

In late February 2026, Mesoblast reported half-year results showing revenue of US$51.34 million, a very large increase from US$3.16 million a year earlier, alongside a narrower net loss of US$40.16 million and reduced loss per share. Soon after, the company issued fiscal 2026 guidance projecting full-year Ryoncil net revenue between US$110 million and US$120 million, giving investors a clearer view of the therapy’s commercial trajectory. With Mesoblast now guiding Ryoncil net revenue of...
ASX:NHC
ASX:NHCOil and Gas

Does New Hope (ASX:NHC)’s Extended Buyback Window Reveal Its True Capital Allocation Priorities?

On March 3, 2026, New Hope extended its on‑market share buyback program by one year, pushing the plan’s expiry to March 2, 2027. This longer buyback window gives the company more flexibility in how it returns capital to investors while gradually shrinking the share base. We’ll now examine how the extended buyback horizon could influence New Hope’s investment narrative and its balance between risks and returns. Find 7 companies with promising cash flow potential yet trading below their fair...
ASX:EOS
ASX:EOSAerospace & Defense

Electro Optic Systems (ASX:EOS) Is Up 10.4% After Profit Return And New Credit Facility News

Electro Optic Systems Holdings reported its 2025 full-year results, with sales of A$128.46 million and net income of A$18.61 million, while simultaneously advancing its global expansion through new defense contracts, a A$100 million credit facility, and a new high-energy laser manufacturing site in Singapore. Alongside returning to profitability, the company has broadened its footprint into India and the Middle East and is integrating higher‑end directed‑energy and counter‑drone technologies...
ASX:TWE
ASX:TWEBeverage

Is Treasury Wine Estates' (ASX:TWE) CFO Exit the Key to a Leaner, Higher-End Portfolio Strategy?

Treasury Wine Estates has announced that Chief Financial and Strategy Officer Stuart Boxer will retire in September 2026, with an internal and external search underway and a multi‑year transformation program targeting A$100 million in annual cost savings and potential divestment of lower-priced brands. The planned, long-dated transition aims to preserve financial and operational continuity while the company reshapes its portfolio and expands production initiatives in China following the...
ASX:SUL
ASX:SULSpecialty Retail

What Super Retail Group (ASX:SUL)'s Higher Sales, Lower Earnings and Steady Dividend Mean For Shareholders

Super Retail Group Limited recently reported half-year results for the period ended 27 December 2025, with sales of A$2,194.7 million and net income of A$104.1 million, and declared a fully franked ordinary dividend of A$0.32 per share payable on 2 April 2026. The company’s higher sales but lower earnings, alongside the affirmed dividend and the appointment of Inga Kirkman as an additional Company Secretary on 26 February 2026, provide fresh insight into how it is balancing growth,...
ASX:AFI
ASX:AFICapital Markets

Assessing Australian Foundation Investment’s Valuation As Buy-Backs And Special Dividends Lift Capital Returns

Buy-back activity and special dividends put capital returns in focus Australian Foundation Investment (ASX:AFI) has stepped up capital returns, combining an active on-market share buy-back with recently declared special dividends. This has put cash distributions and per share outcomes front and centre for investors. See our latest analysis for Australian Foundation Investment. While the latest special dividends and buy-back activity are front of mind, Australian Foundation Investment’s A$6.89...
ASX:HZN
ASX:HZNOil and Gas

Does Horizon Oil (ASX:HZN) Prioritising Dividends Amid Softer Earnings Reveal Its True Capital Allocation Stance?

Horizon Oil Limited recently announced a dividend of A$0.015 per share for the six months ended December 31, 2025, alongside half-year results showing sales of US$44.64 million and net income of US$2.36 million, both lower than the same period a year earlier. The decision to maintain a dividend despite weaker earnings highlights management’s focus on ongoing cash returns to shareholders, even as profitability softens. We’ll now examine how Horizon Oil’s decision to pay this dividend despite...
ASX:IGO
ASX:IGOMetals and Mining

IGO (ASX:IGO) Faces Tighter Kwinana Controls – What Do Health Risks Mean For Operational Flexibility?

The Department of Water and Environmental Regulation recently classified the Tianqi-IGO Kwinana lithium refinery as posing a “high” health risk, prompting tighter operating controls at the plant. This regulatory intervention highlights potential pressure points around compliance and operating flexibility at a refinery that is important to IGO’s lithium processing footprint. We will now examine how the tightened health controls at Kwinana shape IGO’s broader investment narrative and...
ASX:CBA
ASX:CBABanks

Alleged A$1 Billion AI-Linked Mortgage Fraud Could Be A Game Changer For Commonwealth Bank (ASX:CBA)

Commonwealth Bank of Australia has disclosed past exposure to a very limited portion of its own shares and reported itself to authorities over approximately A$1.00 billion in suspected illegitimate home loans allegedly enabled by forged documents and artificial intelligence, with police and regulators now investigating. By flagging that its controlled entities have no net economic exposure to its own voting shares while confronting a large-scale home loan fraud issue, the bank is...
ASX:NEC
ASX:NECMedia

Assessing Nine Entertainment Holdings’ Valuation After Profitability Jumps On Recent Half Year Earnings

Why Nine Entertainment Holdings (ASX:NEC) is Back on Investors’ Radar Nine Entertainment Holdings (ASX:NEC) has moved into the spotlight after its half year earnings update, where net income and earnings per share were far higher than the previous period despite softer sales. On the same day, the company also announced an ordinary dividend of A$0.045 per share for the six months to 31 December 2025, with an ex date of 9 March 2026 and payment scheduled for 23 April 2026. Together, these...
ASX:ZIP
ASX:ZIPConsumer Finance

What Zip Co (ASX:ZIP)'s A$50m Share Buyback Plan Means For Shareholders

Zip Co Limited has launched an on‑market share buyback plan, authorizing the repurchase of up to 92,161,082 shares (7.25% of its 1,270,683,586 issued shares) for A$50,000,000 through to March 5, 2027, following a Board approval on February 20, 2026, and it also presented at the Morgan Stanley Technology, Media & Telecom Conference 2026 at The Palace Hotel in San Francisco on March 2, 2026. This buyback reduces the pool of outstanding shares over time, which can increase each remaining...
ASX:BOE
ASX:BOEOil and Gas

Assessing Boss Energy’s Valuation After Broker Upgrade And Uranium Price Strength

Why Boss Energy is back on investor radars Boss Energy (ASX:BOE) has drawn fresh attention after a broker upgrade to a buy rating, with the case supported by its latest half year earnings, Honeymoon Project progress, and uranium price strength. See our latest analysis for Boss Energy. At A$1.74, Boss Energy’s recent share price return has been mixed, with a 4.19% 90 day gain and 11.18% year to date share price return sitting against a 27.20% 1 year total shareholder return decline. This...
ASX:360
ASX:360Software

Assessing Life360’s Valuation After AI Push And Reaffirmed Growth Outlook

Life360 (ASX:360) has been in focus after reporting strong fourth quarter 2025 results, reaffirming its 2026 revenue guidance of US$640 million to US$680 million and outlining its push toward an AI first platform. See our latest analysis for Life360. Even with the recent guidance and AI first push, Life360’s 7 day share price return of an 11.62% decline and 30 day share price return of a 25.94% decline, alongside a 37.21% year to date share price decline, suggest momentum has cooled in the...
ASX:NAB
ASX:NABBanks

National Australia Bank Leadership Changes Put Risk And Valuation In Focus

National Australia Bank (ASX:NAB) has announced the retirement of Group Chief Risk Officer Shaun Dooley, a 33-year veteran of the bank. Dooley has also been serving as acting Group Chief Financial Officer during a period of leadership change. NAB has appointed Inder Singh as the new Group Chief Financial Officer and Group Executive Strategy. These changes affect core leadership roles that oversee risk management, financial reporting and long term planning. As one of Australia’s major banks,...
ASX:GMD
ASX:GMDMetals and Mining

How Strong Half-Year Gold Output And Earnings At Genesis Minerals (ASX:GMD) Have Changed Its Investment Story

In February 2026, Genesis Minerals Limited reported past-half-year results to 31 December 2025 showing gold production of 147,139 oz, sales of A$820.35 million and net income of A$238.04 million, while keeping its fiscal 2026 production guidance unchanged at 260,000–290,000 oz. The sharp uplift in production and earnings per share from continuing operations, without any change to full-year guidance, suggests the business entered 2026 with stronger operational momentum than in the prior...
ASX:WOW
ASX:WOWConsumer Retailing

A Look At Woolworths Group (ASX:WOW) Valuation After Its Latest Earnings And Higher Fully Franked Dividend

Why Woolworths Group (ASX:WOW) is back in focus after its latest dividend and earnings update Woolworths Group (ASX:WOW) is back on many investors' watchlists after releasing its half year results to 4 January 2026 and lifting its fully franked interim dividend to A$0.45 per share. See our latest analysis for Woolworths Group. Those half year earnings and the higher fully franked dividend have come as Woolworths Group’s share price has logged a 30 day share price return of 16.27% and a year...
ASX:LLC
ASX:LLCReal Estate

Lendlease Group (ASX:LLC) Is Down 6.5% After Swinging To Half-Year Loss And Cutting Distribution – Has The Bull Case Changed?

Lendlease Group has now reported its half-year 2026 results, posting A$2,839 million in sales, a net loss of A$318 million and a basic loss per share of A$0.467, while declaring an ordinary unfranked distribution of A$0.06204589 per security for the six months ended December 31, 2025. The combination of a swing from profit to loss and a lower cash distribution highlights the pressure on Lendlease’s earnings quality and its capacity to fund returns to securityholders from current...
ASX:PME
ASX:PMEHealthcare Services

Assessing Pro Medicus’s Valuation After Director Buying And Upcoming Dividend Attract Attention

Pro Medicus (ASX:PME) is back in focus after co founders and directors bought A$3.4 million of shares on market, with investors also eyeing the upcoming interim dividend payment on March 20. See our latest analysis for Pro Medicus. Despite the director buying and upcoming dividend, Pro Medicus shares have experienced a sharp reset, with a 30 day share price return of a 34.8% decline and a 1 year total shareholder return of a 55.6% decline, contrasting with still positive 3 and 5 year total...